Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection

NCT00163657 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

312

Enrollment

OTHER

Sponsor class

Conditions

End Stage Liver Disease
Hepatitis C

Interventions

DRUG: Daclizumub
DRUG: Tacrolimus
DRUG: Cyclosporine
DRUG: MMF

Sponsor

Baylor Research Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]